Cell Therapy News/Articles, page-5486

Thanks Tunnah for all your hardwork. I absolutely love your contributions.

My read on what is happening isthat it’s all about T-Cells. More specifically Regulatory T cell memory or “MemoryT Cells”. To me, these will be present in the Convalescent Plasma of Coronavirussurvivors – hence the large focus on this therapy.

More importantly for us, MSCscan help signal the activation of these Memory T-Cells in the body. My interpretationis that Convalescent Plasma Transfusions will be the Gold Standard for themasses and our MSCs will be used in the event that the patient’s condition getsworse. Remestemcel-l seems to work best when the patient’s condition is moresevere. By having the Convalescent Plasma transfusion up front, they will havemore chance of survival as our Therapy will be more effective.

Why have do I have this view?

Tonly Fauci focused on thisduring the US House of Representatives hearing into the Coronavirus response.Go to the 1 hour 41 minute mark. He seems very excited about this.

https://www.youtube.com/watch?v=mO4ERWZYy9I

Then our Dear Donald Trump triesto explain Blood Plasma therapy. He does say that Blood Plasma (I keep thinkingof the Austin Powers ”Liquid Magma” skit) is “not the whole answer, but it’s afantastic part of the puzzle”. I suspect Fauci has briefed him.

Also, the NIH, as led by theMount Sinai Health system quickly focused attention on Convalescent Plasma therapysoon after our EAP for Remestemcel-l in 12 patients back in April.

Then, of course, we have the proposed3-pronged approach in Argentina……

An Argentinian Proposal: Mesenchymal Stem Cells,Convalescent Plasma And Dexamethasone In Covid-19. Could Be A Triple StrategyEffective For The Treatment Of Severe Pneumonia Complications?

https://www.heraldopenaccess.us/openaccess/an-argentinian-proposal-mesenchymal-stem-cells-convalescent-plasma-and-dexamethasone-in-covid-19-could-be-a-triple-strategy-effective-for-the-treatment-of-severe-pneumonia-complications